Subject
Developmental Biology,Neurology (clinical),Molecular Biology,General Neuroscience
Reference46 articles.
1. Ambati, M., Apicella, I., Wang, S., Nerendran, S., Leung, H., Pereira, F., Nagasaka, Y., Huang, P., Varshney, A., Baker, K.L., Marion, K.M., Shadmehr, M., Stains, C., Werner, B.C., Sadda, S.R., Taylor, E.W., Sutton, S.S., Magagnoli, J., Gelfand, B.D., 2021. Identification of fluoxetine as a direct NLRP3 inhibitor to treat atrophic macular degeneration. Proc. Nacl. Acad. Sci. U.S.A. 118, e2102975118.
2. Does increasing the ratio of AMPA-to-NMDA receptor mediated neurotransmission engender antidepressant action? Studies in the mouce forced swim and tail suspension tests;Andreasen;Neurosci. Lett.,2013
3. THE ARMS/Kidins220 scaffold protein modulates synaptic transmission;Arévalo;Mol. Cell. Neurosci.,2010
4. β-hydroxybutyrate alleviates depressive behaviors in mice possibly by increasing the histone3-lysine9-β-hydroxybutyrylation;Chen;Biochem. Biophys. Res. Commun.,2017
5. Enhancing AMPA to NMDA throughput as a convergent mechanism for antidepressant action;Du;Drug Discov. Today Ther. Strateg.,2006